Aduro Biotech (ADRO)
14.60 +0.59 (+4.18%) 10/06/20 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Oct 5th, 2020
Results
download Want to compare other data? Select FieldsSymbol | ADRO | AMGN | REGN | VRTX | GILD |
Company | Aduro Biotech | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 14.05 | 276.97 | 705.34 | 422.73 | 92.01 |
High | 14.86 | 276.97 | 707.48 | 428.25 | 92.80 |
Low | 13.92 | 269.78 | 680.89 | 419.27 | 91.68 |
Last | 14.60 | 272.11 | 681.58 | 422.00 | 91.84 |
Change | +0.59 | +2.68 | -11.65 | +5.04 | +0.19 |
% Change | +4.18% | +0.99% | -1.68% | +1.21% | +0.21% |
Volume | 171,500 | 3,244,200 | 1,111,900 | 1,773,500 | 6,862,200 |
20-Day Average Volume | 149,894 | 3,507,620 | 856,940 | 2,097,760 | 6,621,070 |
Previous Close | 14.01 | 269.43 | 693.23 | 416.96 | 91.65 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 12.53 | 263.65 | 709.73 | 410.50 | 91.78 |
20-Day Raw Stochastic | 76.03% | 79.47% | 19.47% | 47.37% | 54.68% |
20-Day Relative Strength | 56.92% | 48.46% | 35.48% | 45.68% | 51.97% |
Weighted Alpha | +96.00 | -14.36 | -35.81 | -7.30 | +15.35 |
Today's Opinion | 40% Buy | 88% Sell | 100% Sell | 72% Sell | 56% Buy |
Previous Opinion | 32% Buy | 88% Sell | 100% Sell | 72% Sell | 40% Buy |
Last Month's Opinion | 56% Buy | 88% Sell | 88% Sell | 24% Sell | 100% Buy |
Performance | |||||
5-Days | |||||
%Chg | +23.16% since 09/28/20 | +3.77% since 01/10/25 | -2.20% since 01/10/25 | +3.04% since 01/10/25 | +2.18% since 01/10/25 |
Low | 11.30 on 10/02/20 | 261.28 on 01/13/25 | 666.25 on 01/13/25 | 397.24 on 01/13/25 | 89.02 on 01/13/25 |
High | 15.73 on 10/02/20 | 276.97 on 01/17/25 | 717.37 on 01/13/25 | 428.25 on 01/17/25 | 93.07 on 01/16/25 |
1-Month | |||||
%Chg | +9.74% since 09/04/20 | +2.32% since 12/17/24 | -7.90% since 12/17/24 | -10.07% since 12/17/24 | -1.03% since 12/17/24 |
Low | 11.00 on 09/24/20 | 253.30 on 12/19/24 | 666.25 on 01/13/25 | 377.85 on 12/19/24 | 88.57 on 01/10/25 |
High | 15.73 on 10/02/20 | 276.97 on 01/17/25 | 745.00 on 12/18/24 | 471.05 on 12/18/24 | 94.55 on 12/26/24 |
3-Month | |||||
%Chg | +16.76% since 07/02/20 | -15.32% since 10/17/24 | -31.72% since 10/17/24 | -15.39% since 10/17/24 | +5.13% since 10/17/24 |
Low | 11.00 on 09/24/20 | 253.30 on 12/19/24 | 666.25 on 01/13/25 | 377.85 on 12/19/24 | 85.60 on 10/22/24 |
High | 17.20 on 08/18/20 | 328.25 on 11/08/24 | 1,002.69 on 10/18/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
6-Month | |||||
%Chg | +14.92% since 04/03/20 | -18.94% since 07/17/24 | -37.22% since 07/17/24 | -13.59% since 07/17/24 | +25.29% since 07/17/24 |
Low | 10.50 on 06/26/20 | 253.30 on 12/19/24 | 666.25 on 01/13/25 | 377.85 on 12/19/24 | 70.78 on 07/23/24 |
High | 17.70 on 05/28/20 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
Key Statistics | |||||
Market Capitalization, $K | 236,614 | 146,268,096 | 74,898,816 | 108,677,232 | 114,457,056 |
Shares Outstanding, K | 16,212 | 537,533 | 109,890 | 257,529 | 1,246,266 |
Annual Sales | 17,260,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
Annual Net Income | -82,370,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
Last Quarter Sales | 5,570,000 | 8,503,000,000 | 3,720,700,000 | 2,771,900,000 | 7,545,000,000 |
Last Quarter Net Income | -16,620,000 | 2,830,000,000 | 1,340,600,000 | 1,045,400,000 | 1,253,000,000 |
60-Month Beta | 0.40 | 0.56 | 0.10 | 0.40 | 0.18 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 5.58 on 10/30/24 | 12.46 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
Latest Earnings Date | 11/05/20 | 02/04/25 | 02/04/25 | 02/03/25 | 02/11/25 |
Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | N/A | 0.770 on 12/13/24 |
Next Ex-Dividends Date | N/A | 02/14/25 | N/A | N/A | 12/13/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.02 | 17.34 | 0.00 | 20.69 |